Northern Trust’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-17,495
| Closed | -$9K | – | 4334 |
|
|
2019
Q4 | $9K | Sell |
17,495
-355
| -2% | -$183 | ﹤0.01% | 4205 |
|
|
2019
Q3 | $68K | Sell |
17,850
-54,605
| -75% | -$208K | ﹤0.01% | 4006 |
|
|
2019
Q2 | $482K | Sell |
72,455
-5,984
| -8% | -$39.8K | ﹤0.01% | 3559 |
|
|
2019
Q1 | $278K | Sell |
78,439
-319
| -0.4% | -$1.13K | ﹤0.01% | 3696 |
|
|
2018
Q4 | $312K | Buy |
78,758
+923
| +1% | +$3.66K | ﹤0.01% | 3663 |
|
|
2018
Q3 | $1.54M | Buy |
77,835
+27,118
| +53% | +$535K | ﹤0.01% | 3339 |
|
|
2018
Q2 | $1.61M | Buy |
50,717
+17,495
| +53% | +$555K | ﹤0.01% | 3311 |
|
|
2018
Q1 | $1.23M | Buy |
33,222
+10,777
| +48% | +$399K | ﹤0.01% | 3314 |
|
|
2017
Q4 | $1.77M | Buy |
+22,445
| New | +$1.77M | ﹤0.01% | 3205 |
|